Response Regarding Application of the CHALF Score in Pediatric Acute Liver Failure

Juliet Emamaullee,Johanna M. Ascher Bartlett,Sarah Bangerth,Kambiz Etesami,Rohit Kohli

DOI: https://doi.org/10.1097/tp.0000000000004962

2024-03-27

Transplantation

Abstract:We thank the group from the Institute of Liver and Biliary Sciences in New Delhi, India, for their interest in our research. Since being published in October 2023, our novel predictive tool, the Children's Hospital-Los Angeles (CHLA) Acute Liver Failure (CHALF) Score, has generated much interest within the pediatric liver transplant community. 1 As indicated in our article, we sought to develop an easily interpreted predictive score of clinical outcomes in pediatric acute liver failure (PALF) exclusively based on common admission lab values to (1) guide early referral/transfer to a liver transplant center for patients who present in the community and (2) inform transplant providers at the time of admission about the urgency to initiate a liver transplant evaluation. The CHALF Score predicts the likelihood of survival with native liver versus liver transplant or death, based on data at the time of admission. Many factors, including underlying cause, clinical trajectory as assessed in real time by the transplant team, and evolution of multiorgan dysfunction, impact the decision to actually proceed with transplant. The CHALF Score was not developed to be used dynamically to predict or inform that decision, although that is something to evaluate moving forward. Ultimately, by rapidly referring patients with higher CHALF Scores to a transplant center, who may then be quickly evaluated for placement on the waitlist, the CHALF Score will likely decrease the chance that patients at risk for rapid clinical deterioration are not yet admitted to a transplant center to receive organ offers at the time when they need them.

immunology,surgery,transplantation